Anna U. Loengard - 06 Jan 2026 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
Director
Signature
/s/Peter J. Rivas as attorney-in-fact for Anna U. Loengard
Issuer symbol
CLOV
Transactions as of
06 Jan 2026
Net transactions value
$0
Form type
4
Filing time
08 Jan 2026, 16:06:44 UTC
Previous filing
14 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Loengard Anna U Director C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON /s/Peter J. Rivas as attorney-in-fact for Anna U. Loengard 08 Jan 2026 0001952723

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Award $0 +79,365 +18% $0.000000 527,456 06 Jan 2026 Direct F1
holding CLOV Class A Common Stock 27,600 06 Jan 2026 By Son IRA F2
holding CLOV Class A Common Stock 29,610 06 Jan 2026 By Daughter IRA F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date.
F2 Held in a custodial IRA for the benefit of Reporting Person's son, for which the Reporting Person serves as custodian.
F3 Held in a custodial IRA for the benefit of Reporting Person's daughter, for which the Reporting Person serves as custodian.